BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld
BioWorld
May 2, 2007
View Archived Issues
Series A And B Rounds Up As Early Stage Model Evolves
Of the $2.1 billion in venture capital invested in global biotechnology companies last quarter, the majority went into earlier-stage financings, according to data from BioWorld Financial Watch and BioWorld Snapshots. (BioWorld Today)
Read More
House Hearing Probes Range Of Ways To Improve The FDA
Read More
Optimer's CDAD Drug Starts Second Pivotal Phase III Trial
Read More
NewCo News: Start-Up Solace Raises $15M In Series A For Pain Drugs
Read More
Italian Firm Eurand Files For IPO On Nasdaq Of Up To $153M
Read More
Other News To Note
Read More
Clinic Roundup
Read More
